Download FREE Report Sample
Download Free sampleCervical dystonia (or spasmodic torticollis) is the most common form of focal or localized dystonia. Neurological in origin, it is characterized by muscular spasms that cause abnormal movements of the neck, head and sometimes the shoulders. The neck muscles may contract, twist, tremble, or remain blocked in one direction, resulting in an awkward and uncomfortable posture.
Cervical Dystonia Therapeutics Market contains market size and forecasts of Cervical Dystonia Therapeutics in Global, including the following market information:
Global Cervical Dystonia Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Cervical Dystonia Therapeutics market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Botulinum Toxins Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cervical Dystonia Therapeutics include Allergan, Eisai, Ipsen Pharma, Merz Pharma and US WorldMeds, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cervical Dystonia Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cervical Dystonia Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Cervical Dystonia Therapeutics Market Segment Percentages, by Type, 2021 (%)
Botulinum Toxins
Drug
Other
Global Cervical Dystonia Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Cervical Dystonia Therapeutics Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Other
Global Cervical Dystonia Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Cervical Dystonia Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cervical Dystonia Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Cervical Dystonia Therapeutics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Allergan
Eisai
Ipsen Pharma
Merz Pharma
US WorldMeds
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
